Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher

Imagine a new weapon in the fight against cancer, a personalized therapy that utilizes the body's own immune system to attack tumors. Science...

Form 8-K - Current report

Form DEF 14A - Other definitive proxy statements

Form PRE 14A - Other preliminary proxy statements

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia

Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia   Miami, FL -- (InvestorsHub...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000

Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000  Miami, FL-- (InvestorsHub NewsWire – November 9, 2023) –...

Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo

Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo   Miami, FL-- (InvestorsHub NewsWire –...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...